Concepedia

Publication | Closed Access

Selected CD133 <sup>+</sup> Progenitor Cells to Promote Angiogenesis in Patients With Refractory Angina

66

Citations

28

References

2014

Year

Abstract

Our findings support feasibility and safety of transendocardial injection of CD133(+) cells in patients with refractory angina. The promising clinical results and favorable data observed in SPECT summed score may set up the basis to test the efficacy of cell therapy in a larger randomized trial.

References

YearCitations

Page 1